186 related articles for article (PubMed ID: 8457037)
21. Allergy to venom from bee or wasp: the relation between clinical and immunological reactions to insect stings.
Heinig JH; Engel T; Weeke ER
Clin Allergy; 1988 Jan; 18(1):71-8. PubMed ID: 3349594
[TBL] [Abstract][Full Text] [Related]
22. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
23. [Therapy control of specific hymenoptera venom allergy].
Aust W; Wichmann G; Dietz A
Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of a Progressively Prolonged Maintenance Interval of Venom Immunotherapy.
Kontou-Fili K; Pitsios C; Kompoti E; Giannakopoulos D; Kouridakis S
Int Arch Allergy Immunol; 2018; 176(1):39-43. PubMed ID: 29649812
[TBL] [Abstract][Full Text] [Related]
25. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
26. Vitellogenins are new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris venom.
Blank S; Seismann H; McIntyre M; Ollert M; Wolf S; Bantleon FI; Spillner E
PLoS One; 2013; 8(4):e62009. PubMed ID: 23626765
[TBL] [Abstract][Full Text] [Related]
27. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
28. The value of immunotherapy with venom in children with allergy to insect stings.
Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
[TBL] [Abstract][Full Text] [Related]
29. [Wasp and bee venom allergy].
Knulst AC; de Maat-Bleeker F; Bruijnzeel-Koomen CA
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):889-92. PubMed ID: 9623183
[TBL] [Abstract][Full Text] [Related]
30. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
[TBL] [Abstract][Full Text] [Related]
31. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy.
Pucci S; Ciccarelli F; De Pasquale T; Illuminati I; D'Alò S
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):376-377. PubMed ID: 29908318
[No Abstract] [Full Text] [Related]
32. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
33. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
[TBL] [Abstract][Full Text] [Related]
34. Natural history of Hymenoptera venom allergy in Eastern Spain.
Fernandez J; Soriano V; Mayorga L; Mayor M
Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
[TBL] [Abstract][Full Text] [Related]
35. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
[TBL] [Abstract][Full Text] [Related]
37. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
Sturm G; Kränke B; Rudolph C; Aberer W
J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
[TBL] [Abstract][Full Text] [Related]
38. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
Fricker M; Helbling A; Schwartz L; Müller U
J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
[TBL] [Abstract][Full Text] [Related]
39. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting.
Blaauw PJ; Smithuis LO
J Allergy Clin Immunol; 1985 May; 75(5):556-62. PubMed ID: 3989140
[TBL] [Abstract][Full Text] [Related]
40. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
Goldberg A; Yogev A; Confino-Cohen R
Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
